Skip to main content

Industry Advocacy

  • Senate files companion legislation to address DIR fees

    ALEXANDRIA, Va. – Four U.S. Senators on Monday introduced bipartisan legislation to boost transparency in Medicare Part D drug spending and to prohibit retroactive “DIR fees.”

  • Excelera Specialty Pharmacy Network joins NASP

    MINNEAPOLIS —ExceleraRx announced Saturday that its Excelera Specialty Pharmacy Network was the newest member of the National Association of Specialty Pharmacy (NASP). 
     
    “We are excited to welcome Excelera members into NASP and important conversations around appropriate access to specialty medications and related services,” NASP membership committee chair Mike Agostino said
     

  • FDA reversal on NDI status cause for concern, industry says

    WASHINGTON – The Food and Drug Administration earlier this week released a Federal Register notice that has major implications for new dietary ingredient notifications and has created a stir among industry advocate groups.

  • NACDS promotes long-standing retail pharmacy advocate to SVP government affairs and public policy

    ARLINGTON, Va. – The National Association of Chain Drug Stores on Thursday promoted Thomas O’Donnell to SVP government affairs and public policy, effective Sept. 7, 2016. O’Donnell has served as VP federal government affairs, since joining the NACDS staff team on July 9, 2012.

    In his new capacity, O’Donnell will report to NACDS president and CEO Steven Anderson.

  • BIO rolls out ‘Innovation Saves’ ad

  • DEA places kratom plant onto schedule I

    WASHINGTON - The Drug Enforcement Administration last week announced its intention to place the active materials in the kratom plant into Schedule I of the Controlled Substances Act in order to avoid an imminent hazard to public safety.

  • PhRMA unveils new ads for ‘From Hope to Cures’ campaign

    WASHINGTON — The Pharmaceutical Research and Manufacturers on Tuesday rolled out new advertising as part of its “From Hope to Cures Campaign,” sharing two patient stories that focus on the theme of “Achievable.”
     

  • Trending 'float industry' driving retail sales of Epsom salts

    SAN FRANCISCO - Growth across the niche "float industry" may be driving sales of Epsom salt at home, according to a release from the San Francisco Salt Company Wednesday. The category reached $127 million in sales on 12.5% growth for the 52 weeks ended July 10 across total U.S. multi-outlet channels, according to IRI data. Retail outlets that provide shallow tubs filled with Epsom salts are trending among consumers in search of deep relaxation experiences.

X
This ad will auto-close in 10 seconds